Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416076 · ClinicalTrials.gov registry record · NA
Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02416076 is a NA study that has completed, run by Ulthera. The registered enrollment target is 42 participants.
The verdict
NCT02416076, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
Up to 40 participants will be enrolled, randomized and treated. Enrolled participants will receive one, split-face Ulthera® treatment on the face and neck using a Ulthera System standard transducer on one side of the face and a Ulthera System prototype simulines transducers on the other side of the face. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
Interventions
- DEVICE Ulthera Treatment at EL2
- DEVICE Ulthera Treatment at EL4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2014-12-15 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02416076
The ClinicalTrials.gov registry entry for NCT02416076 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ulthera Treatment at EL2 is the first listed.
NCT02416076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02416076 about?
NCT02416076 is a clinical study titled "Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers". Up to 40 participants will be enrolled, randomized and treated. Enrolled participants will receive one, split-face Ulthera® treatment on the face and neck using a Ulthera System standard transducer on one side of the face and a Ulthera System prototype simulines transducers on the other side of the ...
What is the current status of trial NCT02416076?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2014-12-15. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02416076?
The interventions under investigation include: Ulthera Treatment at EL2 (DEVICE), Ulthera Treatment at EL4 (DEVICE).
Who is sponsoring clinical trial NCT02416076?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.